Skip Navigation Bar
National Intitutes of Health
This finding aids platform will be replaced in Fall 2022. Please explore the new platform Beta soft release by visiting https://archivesspace.nlm.nih.gov

Robert M. Chanock Papers 1933-2008 (bulk 1950-2008)
search terms in context | full text File Size: 260 K bytes | Add this to my bookbag

Box | Folder Title
 
Research Data, 1950-2008 [subseries]:
28 17-19
Miscellaneous/Unidentified Studies, undated
29 1-7
Miscellaneous/Unidentified Studies (cont'd), 1950-2005
29 8
Japanese B encephalitis, 1951-1954
29 9
Lab studies on adenovirus, pneumonia or bronchiolites, 1952-1956
29 10
Avian Japanese B encephalitis, 1953-1955
29 11
Transplacental transmission polio virus, 1954-1955
29 12
Polio chick embryo, 1955
29 13
Yale - Monkey kidney trypsinization techniques Ph colon test, 1955-1956
29 14
Experiment 2. Assay of a high titer phage stock relation of plaque count to volume of phage suspension plated, 1956
29 15
Etiology of nonbacterial respiratory disease in infancy and childhood - NIH senior fellowship grant, 1956
29 16
Serology, 1956-1957
69 9
1 RSV collation, 1956-1957 [RESTRICTED PHI POLICY]
29 17
Croup, 1956-1959
29 18
Pap virus, 1958-1959
69 11
Mycoplasma - U.S. Naval Hospital, Beaufort, S.C. - patient summaries, 1959-1960 [RESTRICTED PHI POLICY]
29 19
Respiratory viruses and mycoplasmas clinical: Pap study - Parris Island, 1959-1961
29 20
#2 neutralization tests #19, 1959-1998
29 21
Immunization, 1961-1962
69 14-15
RS vaccine study, 1962-1975 [RESTRICTED PHI POLICY]
29 22
Contribution of adenoviruses to respiratory tract illness among children, 1963
29 23
Evaluation of WI-26 human diploid fibroblast cultures for isolation of adenovirus type 4, 1963
29 24-25
Lots of vaccine - Wyeth, 1963-1968
29 26-27
Mycoplasma, 1963-1992
29 28
Ludwig adeno capsule, 1964
29 29
Respiratory viruses and mycoplasmas clinical: adeno field trials - Parris Island, 1964-1965
30 1
Respiratory viruses and mycoplasmas clinical: m. pneumonia trials - Parris Island, 1965-1966
30 2
Respiratory viruses and mycoplasmas clinical: rs attenuated strain - 2, 1965-1970
69 18
Children's Hospital contract reports, 1965-1981 [RESTRICTED PHI POLICY]
30 3
Drug protocols - Wyeth, 1966
30 4
Respir. Viruses and mycoplasmas clinical: adeno field trials other, 1966-1967
69 17
RS vaccine study, 1967 [RESTRICTED PHI POLICY]
30 5
Experimental rubella vaccine lot 12-6/6A, 1967
30 6
Myxovirus recovery from respiratory tract illness - summary tables, 1967
30 7
Camargo, Ena - RSV - paraflu III plaque, 1967-1972
30 8-13
RS vaccine - Children's Hospital of D.C., 1967-1979
30 14-16
Production protocol - adenovirus vaccine, life, oral - type 7 - Wyeth, 1968-69
30 20
RS #3 challenge of para 1 new, November 1970
30 17
RS ts 1 mutant - Jessup, 30 December 1969
30 18
Clinical research protocols, 1969-1978
30 19
RS volunteer - wild type challenge of ts1 vaccinees, 13 February 1970
30 21
DBS-IND-294 Wyeth, adenovirus vaccine, type 7, live, oral - book 2, 1970-1972
30 22
Antibody response to m. pneumoniae vaccine, 1971
30 23
RSV clinical summary - Children's Hospital, 1971
30 24
Virus-associated immunopathology animal models and implications for human diseases, c.1972
30 25
RSV primates: to RS in children, c.1972-1973
69 23
Children's Hospital - nasal washings, 1972-1974 [RESTRICTED PHI POLICY]
30 26
Lab reports, 1973
30 27
Influenza A/1968 (H3N2) virus serum hemagglutination - inhibition antibody status of children before and after the Nov. 1972-Jan. 1973 epidemic of influenza A/1972 (H3N2) in Washington, D.C., 1973
30 28
Clinical observation of infants/children receiving RS-A2, ts-1 mutant, 1973
30 29
Mycoplasma vaccine trial (OSU-1) - Naval Medical Field Research Laboratory, 1974
30 30
Safety test protocol - A/Georgia/101/74 clone 1B, 1974
30 31
RS vaccine summaries - Children's Hospital, 1974-1975
31 1
RSV primates: bovine RSV in cotton rats, owl monkeys and chimps, 1974-1993
31 2
Swine influenza - Burroughs Wellcome Research Labs, 1975-1979
31 3
Camargo, Ena - RSV, 1975-1980
31 4
Huebner tumorigenicity TS-1-E (Morris), 1976
31 5
Status of two dose trials, 1976
31 6
Safety test - parainfluenza virus type 3, strain #22311 (lot F-367), 1976
31 7
RSV primates: genetic stability - stress tests RS, 1976-1989
31 8
Safety test of influ. A/VIC/3/75 (H3N2) x ts-1 [E], clone 81C1, recomb. virus (code CF/PP/1) - Flow Labs, 1977
31 9
Lot F-486 - RSV, strain A2, TS-1 NG-16 mutant, 1977-1979
31 10
RSV primates II, 1977-1991
31 11
Attenuated influenza vaccines, 1981
31 12
Nasal washings - Children's Hospital, 1981
31 13
RSV hr mutants in primates ts in primates: guinea pig kidney cell grown RSV - pass 18 chimps, 1981
31 14
RSV primates: cotton rat RS, 1981
31 15
RSV hr mutants in primates ts in primates: chick lung cell grown RSV passage 6 - chimps, 1982
31 16
RSV primates, 1982-1993
31 17
Research labs - Merck Sharp and Dohme, 1983-1991
31 18
SV40, 1983-2001
31 19-20
Production protocols - Wyeth, 1985
31 21
RSV hr mutants in primates ts in primates: primates studies RSV, 1986-1990
31 22
Immunization: flavi and alpha viruses, 1988
31 23
Prophylactic effect antibodies, 18 October 1988
31 24
MF59 Chiron, 1989-2006
31 25
RSV vaccine testing, 1989-2006
31 26
Fourth NIH rotavirus vaccine workshop, 5-6 November 1990
31 27
RSV ICN Krugman, 1991-1993
31 28
Flavivirus vaccine research - Walter Reed-NIAID, 1991-1994
31 29-30
RSV human fob monoclones, December 1991-February 1995
31 31
CA influenza virus - Wyeth, 1992-1993
31 32
RSV - Repligen, 1993
31 33
Fab 19 MARM, 1993-1995
31 34
RSV human FABS, 5 February 1995
31 35-36
AGMK cells, karyotype, tumor tests, patent, 1994-2000
32 1-3
Bovine RV (4x) clinical trial, 1997
32 4
U.S.-Russian collaboration final report, 1997
32 5-7
TBEV LGT, 1998-2000
32 8-9
TBEV II and West Nile, 2000
32 10
History of discovery and development of successful interventions, 2000
32 11
West Nile virus, 2000-2006
32 12
Periodic dengue, West Nile, TBEV meetings, 2001
32 13-14
Dengue vaccine part II, 2001-2007
33 13
Dengue virus and West Nile virus, 2008
32 15
Dengue virus vaccine development, 2002
33 1
TBEV and Langat II, 2002
33 2
Dengue virus vaccine data, 2003
33 3
Restoration of live adenoviruses vaccine in DOD, 2003-2005
33 4-6
Negative SV40, 2004
33 7-8
Positive SV40, 2004
33 9
Dengue virus vaccine development, 2004
33 10
Clinical WN/Den4 serology immunogenicity - clinical Lat/Den4 serology immunogenicity, 2005
33 11
Dengue candidates, August 2006
33 12
Den langat, 2006